DEC 12, 2019 9:00 AM PST

Psychiatric Pharmacogenomics: Practical Applications for the Community Psychiatrist

C.E. Credits: CME
Speaker
  • Clinical Psychiatrist, Watson Clinic, LLP
    Biography
      Dr. Joachim Benitez is on staff at the Watson Clinic, LLP, serving as a community psychiatrist in Lakeland, Florida. He was formerly a dual appointee working as an Assistant Clinical Professor at Weill-Cornell University and at Columbia University in New York City. As part of the attending teaching staff, he was charged with the education of residents and medical students, and the formation and training of future thought leaders in the field. He was also involved in research and writing, and his academic pursuits have followed him since his training years at the Mayo Clinic where he became involved early on in pharmacogenomics and their unique clinical applications under the mentorship of Dr. David Mrazek, former Chair of Psychiatry at the Mayo Clinic, and one of the fathers of Psychiatric Pharmacogenomics. Dr. Benitez has over a decade of experience using pharmacogenomic tests to provide patients with individualized and personalized medicine, delivering care using the guiding principle of giving each and every patient the right drug, at the right dose, at the right time. He received his medical degree from St. Luke's College of Medicine, completed his residency in Psychiatry at the Mayo Clinic, and worked at the Mayo Clinic Health System - Austin, where he served as Department Chair of Psychiatry. He worked at the prestigious Payne Whitney Partial Hospital Program, and at Columbia University Medical Center CPEP, as an educator, a researcher, and a clinician who provided compassionate, expert, and state-of-the-art care to patients who have struggled with the most complicated and the most treatment-resistant psychiatric conditions.

    Abstract
    DATE:  December 12, 2019 - December 12, 2020
    This activity is provided by Global Education Group.    
     
    The Community Psychiatrist is at the vanguard of the mental health crisis afflicting the nation, providing care to the patients where it is most needed. It is in this scenario where we see the day to day struggle of the everyday psychiatric patient who encounters treatment resistance, or a plethora of side effects, which may curtail the desire of the average patient, already stigmatized by society because of their mental illness, from seeking proper Psychiatric care. Psychiatric Pharmacogenomics is a tool in the armamentarium of the Community Psychiatrist to cut through that treatment resistance, limit side effects, and ultimately, improve outcomes for the patients in the community who experience unnecessary hardships brought about by their oft difficult to treat conditions. There are certain genes and genotypes which we will review that are relevant to test for patients with psychiatric issues. There are practical applications for these tests which can justifiably be utilized after repeated treatment failure or experiencing vicious side effects, and in some cases, even prior to embarking a medication trial. Finally, there are basic resources on pharmacogenomic drug information that a well informed psychiatrist should be aware of when prescribing psychotropics that can guide treatment in the present and moving forward.
     
    Learning Objectives:
    • Discuss the difference between pharmacokinetics and pharmacodynamics

    • Describe certain Cytochrome p450 substrates, inducers, and inhibitors that affect drug metabolism, and online resources to help you negotiate these issues

    • Evaluate PharmGKB and find genes and meds that might help you guide your treatment

    • Explain why the patient might be right and Lithium might not always be the “gold standard” in treatment

     
    Continuing Medical Education (CME) Credits: 

    Target Audience
    The educational design of this activity addresses the needs of MDs, PhDs, and typical community psychiatrists seeing patients from 9 to 5, doing psychopharmacology work

    Physician Accreditation Statement
    Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Physician Credit Designation
    Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Term of Offering
    This activity was released on 12/12/2019 and is valid for one year. Requests for credit must be made no later than 12/12/2020.

    Global Contact Information
    For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

    Instructions for Obtaining Credit
    In order to receive credit, participants must view the entire webinar, and then complete both the evaluation and posttest, at which time they will be sent a certificate via email for downloading.

    Disclosure of Conflicts of Interest
    Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Faculty or Presenter

    Reported Financial Relationship

    Joachim Benitez

    Nothing to disclose

     

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Planner or Manager

    Reported Financial Relationship

    Lindsay Borvansky

    Nothing to disclose

    Andrea Funk

    Nothing to disclose

    Liddy Knight

    Nothing to disclose

    Ashley Cann

    Nothing to disclose

    Tracy Salcido

    Nothing to disclose

    Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and LabRoots do not recommend the use of any agent outside of the labeled indications.  

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

     

    * There is no fee for this educational activity


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 03, 2020 4:30 PM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    Loading Comments...
    Show Resources
    Attendees
    • See more